title: Editorial: safety and tolerability of rifaximin for IBS - more information is required; authors' reply.
authors.affiliation: Division of Gastroenterology, University of Michigan School of Medicine, Ann Arbor, MI, USA. pschoenf@umich.edu.
authors.forename: P
authors.initials: P
authors.lastname: Schoenfeld
authors.forename: M
authors.initials: M
authors.lastname: Pimentel
mesh_terms: D005260:Female; D005765:Gastrointestinal Agents / Q000009:adverse effects*; D006801:Humans; D043183:Irritable Bowel Syndrome / Q000188:drug therapy*; D008297:Male; D012294:Rifamycins / Q000009:adverse effects*
chemical_list: D005765:Gastrointestinal Agents; D012294:Rifamycins